Mereo BioPharma Group (MREO) News Today $1.74 +0.04 (+2.35%) Closing price 08/25/2025 04:00 PM EasternExtended Trading$1.74 0.00 (0.00%) As of 08/25/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MREO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 25 at 1:12 PM | globenewswire.comAberdeen Group plc Acquires New Holdings in Mereo BioPharma Group plc - Sponsored ADR $MREOAugust 23 at 4:34 AM | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 22, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 21, 2025 | globenewswire.comCantor Fitzgerald Has Positive View of MREO FY2026 EarningsAugust 17, 2025 | marketbeat.comQ3 EPS Forecast for Mereo BioPharma Group Reduced by AnalystAugust 17, 2025 | marketbeat.comTejara Capital Ltd Purchases 204,239 Shares of Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO)August 17, 2025 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Upgraded at Wall Street ZenAugust 17, 2025 | marketbeat.comAnalysts Offer Predictions for MREO Q1 EarningsAugust 16, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 16, 2025 | prnewswire.comAnalysts Set Expectations for MREO Q3 EarningsAugust 16, 2025 | marketbeat.comWhat is Lifesci Capital's Forecast for MREO Q3 Earnings?August 16, 2025 | americanbankingnews.comQ3 Earnings Forecast for MREO Issued By Leerink PartnrsAugust 16, 2025 | americanbankingnews.comMereo BioPharma Group (NASDAQ:MREO) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPSAugust 14, 2025 | marketbeat.comMereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Receives Average Rating of "Buy" from AnalystsAugust 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 13, 2025 | globenewswire.comMereo BioPharma Group plc: Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate HighlightsAugust 13, 2025 | finanznachrichten.deMereo BioPharma Reports Increased Losses Amid Strategic FocusAugust 13, 2025 | msn.comMereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate HighlightsAugust 12, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 11, 2025 | prnewswire.comMereo BioPharma Group (MREO) Expected to Announce Earnings on TuesdayAugust 6, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOAugust 6, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOJuly 31, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOJuly 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOJuly 27, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOJuly 22, 2025 | prnewswire.comMereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO) Given Consensus Rating of "Buy" by BrokeragesJuly 19, 2025 | marketbeat.comMereo BioPharma Group (NASDAQ:MREO) Lowered to Sell Rating by Wall Street ZenJuly 19, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREOJuly 17, 2025 | prnewswire.comMereo BioPharma Group Stock Short Interest Report | NASDAQ:MREO - BenzingaJuly 11, 2025 | benzinga.comMereo BioPharma Group Analyst Ratings and Price Targets | NASDAQ:MREO ...July 11, 2025 | benzinga.comMereo BioPharma: Buy Rating Despite No Early Study Completion Of Setrusumab For OIJuly 10, 2025 | seekingalpha.comUltragenyx, Mereo Hammered For Their Surprise Miss In Brittle Bone DiseaseJuly 10, 2025 | investors.comMereo BioPharma Group (NASDAQ:MREO) Price Target Lowered to $5.00 at Needham & Company LLCJuly 10, 2025 | marketbeat.comUltragenyx Pharmaceutical Inc.: Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final AnalysisJuly 10, 2025 | finanznachrichten.deMereo BioPharma Group plc (MREO) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comUltragenyx, Mereo Slide as Drug Study Progresses to Final AnalysisJuly 9, 2025 | marketwatch.comMREO | Mereo BioPharma Group PLC ADR - Wall Street JournalJune 29, 2025 | wsj.comResearch Analysts Issue Forecasts for MREO FY2026 EarningsJune 11, 2025 | marketbeat.comInvestors Purchase Large Volume of Call Options on Mereo BioPharma Group (NASDAQ:MREO)June 6, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in Mereo BioPharma Group plc (NASDAQ:MREO)June 5, 2025 | marketbeat.comMereo BioPharma Group plc (NASDAQ:MREO) Given Consensus Recommendation of "Buy" by AnalystsMay 31, 2025 | marketbeat.comWoodline Partners LP Buys Shares of 618,784 Mereo BioPharma Group plc (NASDAQ:MREO)May 27, 2025 | marketbeat.comTema Etfs LLC Invests $3.12 Million in Mereo BioPharma Group plc (NASDAQ:MREO)May 20, 2025 | marketbeat.comJanus Henderson Group PLC Boosts Stock Holdings in Mereo BioPharma Group plc (NASDAQ:MREO)May 16, 2025 | marketbeat.comMereo BioPharma Group (MREO) to Release Quarterly Earnings on WednesdayMay 16, 2025 | marketbeat.comWe're Not Very Worried About Mereo BioPharma Group's (NASDAQ:MREO) Cash Burn RateMay 15, 2025 | finance.yahoo.comMereo BioPharma Group (NASDAQ:MREO) Receives "Buy" Rating from Needham & Company LLCMay 15, 2025 | marketbeat.comMereo BioPharma Group plc: Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate HighlightsMay 13, 2025 | finanznachrichten.deMereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate HighlightsMay 13, 2025 | globenewswire.com Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address MREO Media Mentions By Week MREO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MREO News Sentiment▼0.710.70▲Average Medical News Sentiment MREO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MREO Articles This Week▼53▲MREO Articles Average Week Get Mereo BioPharma Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MREO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RCUS News Today LENZ News Today SYRE News Today UPB News Today STOK News Today VERV News Today PRAX News Today VALN News Today CRMD News Today MLYS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MREO) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mereo BioPharma Group plc - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Mereo BioPharma Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access